These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8924222)

  • 1. Superantigen and class II MHC molecules.
    Kim J
    J Korean Med Sci; 1995 Dec; 10(6):393-8. PubMed ID: 8924222
    [No Abstract]   [Full Text] [Related]  

  • 2. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.
    Arcus VL; Proft T; Sigrell JA; Baker HM; Fraser JD; Baker EN
    J Mol Biol; 2000 May; 299(1):157-68. PubMed ID: 10860729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding kinetics of superantigen with TCR and MHC class II.
    Alam SM; Gascoigne NR
    Methods Mol Biol; 2003; 214():65-85. PubMed ID: 12489455
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions between staphylococcal superantigens and MHC class II molecules.
    Labrecque N; Thibodeau J; Sékaly RP
    Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors.
    Papageorgiou AC; Tranter HS; Acharya KR
    J Mol Biol; 1998 Mar; 277(1):61-79. PubMed ID: 9514739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigen engineering.
    Abrahmsén L
    Curr Opin Struct Biol; 1995 Aug; 5(4):464-70. PubMed ID: 8528762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIalpha.
    Krupka HI; Segelke BW; Ulrich RG; Ringhofer S; Knapp M; Rupp B
    Protein Sci; 2002 Mar; 11(3):642-51. PubMed ID: 11847286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
    Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
    J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superantigens. Structure, function, and diversity.
    Baker MD; Acharya KR
    Methods Mol Biol; 2003; 214():1-31. PubMed ID: 12489451
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of two classes of MHC molecules elucidated: crucial differences and similarities.
    Bjorkman PJ; Burmeister WP
    Curr Opin Struct Biol; 1994 Dec; 4(6):852-6. PubMed ID: 7712289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
    Kum WW; Laupland KB; Chow AW
    Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigens of gram-positive bacteria: structure-function analyses and their implications for biological activity.
    Kotb M
    Curr Opin Microbiol; 1998 Feb; 1(1):56-65. PubMed ID: 10066470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
    Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
    Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
    Nilsson H; Björk P; Dohlsten M; Antonsson P
    J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation.
    Sundberg EJ; Andersen PS; Schlievert PM; Karjalainen K; Mariuzza RA
    Structure; 2003 Sep; 11(9):1151-61. PubMed ID: 12962633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigen Recognition and Interactions: Functions, Mechanisms and Applications.
    Deacy AM; Gan SK; Derrick JP
    Front Immunol; 2021; 12():731845. PubMed ID: 34616400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection and function of CD4+ T lymphocytes in transgenic mice expressing mutant MHC class II molecules deficient in their interaction with CD4.
    Gilfillan S; Shen X; König R
    J Immunol; 1998 Dec; 161(12):6629-37. PubMed ID: 9862691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.